Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Cancer Research|October 20, 2004
A gene expression signature associated with metastatic outcome in human leiomyosarcomasYin-Fai Lee, Megan John, Alison Falconer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 31, 2012
Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancerAlison H M Reid, Gerhardt Attard, Daniel Brewer, et al.
Oncogene|January 13, 2004
Amplification and overexpression of E2F3 in human bladder cancerAndrew Feber, Jeremy Clark, Graham Goodwin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2008
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone drivenGerhardt Attard, Alison H M Reid, Timothy A Yap, et al.
Endocrine-Related Cancer|January 7, 2015
HES5 silencing is an early and recurrent change in prostate tumourigenesisCharles E Massie, Inmaculada Spiteri, Helen Ross-Adams, et al.
The Lancet. Oncology|October 13, 2012
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage studyDavid Olmos, Daniel Brewer, Jeremy Clark, et al.
Cancer Research|January 28, 2010
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formationMartin K Thomsen, Laurence Ambroisine, Sarah Wynn, et al.
Science Translational Medicine|September 3, 2025
The landscape of microbial associations in human cancerAbraham Gihawi, Henry M Wood, Jeremy Clark, et al.
Carcinogenesis|May 15, 2010
Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesionSebastiano Battaglia, Orla Maguire, James L Thorne, et al.
Pageof 8